Disease: Hepatic fibrosis
- <sup>99m</sup>Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications
- A comprehensive review of miR-21 in liver disease: Big impact of little things
- A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development
- A Long-Acting LEAP2 Analog Reduces Hepatic Steatosis and Inflammation and Causes Marked Weight Loss in Mice
- A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis
- A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis
- A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply
- A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease
- Adipokine (adiponectin-rs1501299) Gene Variant and Patient Characteristics in Relation to Metabolic-associated Fatty Liver Disease
- Alarming rate of liver cirrhosis after the small conduit Extracardiac Fontan. A comparative analysis with the Lateral Tunnel
- An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients
- Angiogenesis and Microvascular Permeability
- Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
- Arbutin ameliorates liver fibrosis in mice by inhibiting macrophage recruitment and regulating the Akt/NF-kappaB and Smad signaling pathways
- Calreticulin regulates hepatic stellate cell activation through modulating TGF-beta-induced Smad signaling
- Cardiac lipotoxicity and fibrosis underlie impaired contractility in a mouse model of metabolic dysfunction-associated steatotic liver disease
- Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
- Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study
- Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank
- Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study
- Clinical Presentation, Pathological Spectrum, and Outcomes of Alcoholic Cirrhosis-Related Immunoglobulin A Nephropathy
- Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study
- Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis
- Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings
- Dengue-related acute liver failure-A scoping review
- Development and validation of a nomogram for predicting in-hospital mortality of intensive care unit patients with liver cirrhosis
- Development of a nomogram for predicting in-hospital mortality in patients with liver cirrhosis and sepsis
- Diagnostic performances of Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction-associated steatotic liver disease in Asian primary care clinics
- Dietary inflammatory impact on NAFLD development in obese vs. lean individuals: an analysis based on NHANES 2003-2018
- Does SLC39A8 Ala391Thr confer risk of chronic liver disease?
- Dynamic liver volume change in predicting hepatic decompensation and long-term effects of stereotactic body radiation therapy
- Echocardiographic Assessment of Right Ventricular Function in Patients With Liver Cirrhosis
- Effect of Nonpharmacological Methods on Pruritus in Patients with Liver Disease and Liver Cirrhosis: Systematic Review
- Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross-sectional retrospective study
- Efficacy and Safety of Aldafermin in Non-Alcoholic Steatohepatitis: A systematic review and meta-analysis of randomized controlled trials
- Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database
- Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis
- Expression of 10 circulating cytokines/chemokines in HBV-related liver disease
- Expression of Fascin-1 and its diagnostic value in liver cancer
- Expression of PVT-1 and miR-29a/29b as reliable biomarkers for liver cirrhosis and their correlation with the inflammatory biomarkers profile
- Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3-year prospective cohort study
- Farnesoid X receptor modulator 12beta-(m-methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways
- Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)
- Fisetin ameliorates methotrexate induced liver fibrosis
- Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study
- Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease-related hepatocellular carcinoma
- Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications
- High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
- Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trial
- Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis
- Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infection
- Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism
- Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians
- Impact of sarcopenia on variceal rebleeding in patients after endoscopic therapy: a multicenter retrospective cohort study based on propensity score matching
- Kupffer cell diversity maintains liver function in alcohol-associated liver disease
- Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- MASLD/MASH and type 2 diabetes: two sides of the same coin? From single PPAR to pan-PPAR agonists
- Mechanism of Si Ni San Combined with Astragalus in Treating Hepatic Fibrosis: A Network Pharmacology and Molecular Docking Study
- Metabolic disorders induced the changes in the expressions of TNFalpha, E-cadherin and ultrastructural alteration of liver cells in a typical animal model of type 2 diabetes: Psammomys obesus
- Metabolic dysfunction-associated steatohepatitis treated by poly(ethylene glycol)-block-poly(cysteine) block copolymer-based self-assembling antioxidant nanoparticles
- NAC1 transcriptional activation of LDHA induces hepatitis B virus immune evasion leading to cirrhosis and hepatocellular carcinoma development
- Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease
- Outpatient Management of Symptomatic Ascites: Bypassing the Path of Least Resistance
- Pathological, morphological, and molecular characterization of the infection by Brachycladium goliath in humpback whale Megaptera novaeangliae
- Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- Pediococcus pentosaceus Endocarditis in a Patient With Recent Transcatheter Aortic Valve Implantation and Liver Cirrhosis: A Case Report and Review of the Literature
- Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
- Positive impact of obesity on the prognosis of liver cirrhosis
- Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease
- Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation
- Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study
- Prevalence of Pulmonary Hypertension in Liver Cirrhosis Patients: A Cross-Sectional Analytical Study
- Protective role of 17beta-estradiol in alcohol-associated liver fibrosis is mediated by suppression of integrin signaling
- Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management
- RASSF4 attenuates metabolic dysfunction-associated steatotic liver disease progression via Hippo signaling and suppresses hepatocarcinogenesis
- Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
- Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease
- Reply: Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis - A randomized controlled trial
- Review article: Evaluation and care of the critically ill patient with cirrhosis
- RNA-sequencing suggests extracellular matrix and vasculature dysregulation could impair neurogenesis in schizophrenia cases with elevated inflammation
- Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study
- Role of FXR in the development of NAFLD and intervention strategies of small molecules
- Role of resmetirom, a liver-directed, thyroid hormone receptor beta-selective agonist, in managing non-alcoholic steatohepatitis: a systematic review and meta-analysis
- Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV
- SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
- Spectrum of COVID-19 induced liver injury: A review report
- Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?
- Technique efficacy and complications after ablation as first surgical intervention for hepatocellular carcinoma: A nationwide database study
- The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity-A prospective biopsy-controlled study
- The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis scoring among NAFLD patients: a retrospective cross-sectional study
- The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review
- The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD
- The gut-liver axis in fatty liver disease: role played by natural products
- The mitochondrial multi-omic response to exercise training across rat tissues
- The role of anoctamin 1 in liver disease
- Thy-1 restricts steatosis and liver fibrosis in steatotic liver disease
- Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients
- TRIF-dependent signaling and its role in liver diseases
- ZNF469 is a profibrotic regulator of extracellular matrix in hepatic stellate cells